Please ensure Javascript is enabled for purposes of website accessibility

Monsanto Needs to Round Up Some Growth

By Brian Orelli, PhD – Updated Apr 6, 2017 at 1:25PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

So much for New Year's resolutions.

Even with two hemispheres to work with, the agriculture industry is still fairly cyclical on a yearly basis with Monsanto (NYSE:MON) often reporting fiscal fourth-quarter losses. The start of its fiscal year in September is supposed to be a time to regroup and get the year off to a good start.

Not this year.

Monsanto announced a $0.03 first-quarter loss today compared with $1.00 per share of income a year ago. That's not exactly getting off on the right foot.

The culprit, as has been the case for a couple of quarters: Roundup. The previous cash cow has run out of milk, with sales of the herbicide slipping 63% year over year as generic competition ate into both volume and prices. The latter is evident by the substantial hit to the company's gross margin, down 15 percentage points to 44%.

This is where I'd usually point out that the future of the company -- biotech seeds -- made up for some of the loss. Only it didn't. Both corn and soybean sales fell year over year, and increases in vegetable and cotton seeds couldn't make up the difference. Monsanto expects some of the soybean sales will be shifted into the second quarter as the company got a late start in selling seeds. 

But the corn may be a lost cause; farmers aren't planting as much in Brazil and Argentina for a variety of reasons, including decreased commodity prices. That's not good news for other seed makers such as DuPont (NYSE:DD) and Dow Chemical (NYSE:DOW), others in the agriculture industry such as Deere & Co. (NYSE:DE), and fertilizer producers like PotashCorp (NYSE:POT) and Agrium (NYSE:AGU).

I think it's safe to call 2010 a rebuilding year for Monsanto. The company plans to make up for the loss as the fiscal year progresses and reiterated its adjusted earnings guidance of $3.10 to $3.30 per share for the year -- still a far cry from the $4.41 per share last year. Rather than focus on 2010 earnings, long-term investors would be better off focusing on the company's pipeline of new seed products. With 11 products having moved closer to market in the last year, 2011 and 2012 could turn out to be the new beginning that Monsanto needs.

Monsanto is a recommendation of the Inside Value newsletter. The Inside Value team scours high and low to bring you the best value stocks available. Check it out for free with a 30-day trial.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Monsanto Company Stock Quote
Monsanto Company
MON
Nutrien Stock Quote
Nutrien
POT
Deere & Company Stock Quote
Deere & Company
DE
$334.22 (-3.44%) $-11.91
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company
DD
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DOW

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.